news
Dr. Jitendra Singh inaugurated a SAMARTH Skill Centre and a technology incubator at the Centre for DNA Fingerprinting and Diagnostics in Hyderabad, marking India's shift towards genomics and biotechnology in healthcare. The Minister highlighted the government's focus on early detection, personalised medicine, and affordable treatment, especially
news
Union Minister Dr. Jitendra Singh inaugurated the new BRIC Secretariat in New Delhi, marking a significant step towards enhancing India's bioeconomy. The office will coordinate across 14 institutes under the Biotechnology Research and Innovation Council for better collaboration and integration, under the Department of Biotechnology's BioE3
news
In 2025, India has observed significant advancements in its biotechnology sector, propelled by government-supported initiatives and policies. The country's bio-economy has scaled markedly, from $10 billion in 2014 to $165.7 billion in 2024, with projections to reach $300 billion by 2030. The Department of Biotechnology has been
Biotechnology
During the Second Foundation Day of the Biotechnology Research & Innovation Council (BRIC), Dr. Jitendra Singh emphasized India's leadership in the biotechnology sector, highlighting the country's exclusive Biotechnology policy, BiOE3. He announced the launch of the BRIC–BIRAC Entrepreneur-in-Residence Program and noted the significant growth of
Bioinnovation
Union Minister Dr. Jitendra Singh emphasized the importance of leveraging regional strengths to build a robust bioinnovation ecosystem in India during a review meeting of the Department of Biotechnology (DBT). He highlighted ongoing projects aimed at expanding the country's bio-innovation landscape, including the mapping of states based on
Nafithromycin
India has successfully developed its first indigenous antibiotic, Nafithromycin, effective against resistant respiratory infections, particularly benefiting cancer patients and diabetics. This achievement, a collaboration between the Department of Biotechnology and Wockhardt, highlights the importance of a self-sustainable innovation ecosystem. Additionally, a breakthrough in gene therapy for Hemophilia has been reported,
Gene Therapy
Dr. Jitendra Singh inaugurated the 10th Annual 'Cell and Gene Therapy' Symposium at CMC Vellore, highlighting CSCR's achievement in India's first human gene therapy trial for Hemophilia A. He emphasized the importance of affordable gene therapy and advancements in India's biomanufacturing sector,
Pharma Exports
India's pharmaceutical exports, currently valued at approximately $27.8 billion, are projected to exceed $30 billion by the end of this year, according to Dr. Jitendra Singh, Union Minister of State for Science and Technology. The domestic pharma market, valued at $60 billion, is expected to double to
Biotechnology
At the SYMRESEARCH 2.0 conference, Dr. Jitendra Singh emphasized biotechnology as the cornerstone of India's future economy and healthcare, likening it to the IT revolution of the 1990s. He highlighted significant growth in the biotech sector, government initiatives like the Bio-E3 policy, and the importance of integrating
BioE3 Policy
The International Centre for Genetic Engineering and Biotechnology (ICGEB) in New Delhi hosted an event to commemorate the first anniversary of the BioE3 Policy, a government initiative integrating biotechnology with economy, environment, and employment. The event featured discussions on accelerating the lab-to-market transition of innovations in agriculture and clean energy,
IIT Roorkee
In his convocation address, Dr. Jitendra Singh praised IIT Roorkee as Asia's first engineering college and emphasized its role in research, innovation, and societal engagement. He highlighted the institution's ranking as 6th in the country and its contribution to India's startup ecosystem with nearly
Science and Technology
Union Minister Dr. Jitendra Singh chaired a high-level review meeting of Science Secretaries at Kartavya Bhavan, focusing on boosting startups, preparations for the Indian International Science Festival (IISF), and the Emerging Science, Technology & Innovation Conclave (ESTIC). He emphasized the importance of biotechnology and the Bio-E3 policy, while reviewing the